Table 4.

Pregnancy outcomes according to the results of point of care IL-6 (using cut-off: 745 pg/ml)

	Negative point of care IL-6 (Group 1) (n=22)	Positive point of care IL-6 (Group 2) (n=34)	P value
Amniotic fluid glucose (mg/dl)	25.5 (11.5–32.75)	14 (10–22)	0.01
Amniotic fluid WBC (cell/m3)	4.5 (0–38)	27 (6.8–262.5)	0.01
Gestational age at amniocentesis (weeks)	30.65 (28–31.78)	27 (22.7–30.48)	0.005
Microbial invasion of the amniotic cavity (MIAC)	18.2% (4/14)	29.4% (10/34)	0.34
Gestational age at delivery (weeks)	31.8 (30.6–33.18)	28.9 (23.48–32.78)	0.008
Delivery < 28 week (n=19)	50% (2/4)	89.5% (17/19)	0.06
Delivery < 34 week (n=54)	95.5% (21/22)	97.1% (33/34)	0.75
Birthweight (grams)	1752.5 (1398.8–2108.8)	1220 (524–1777.5)	0.03
ELISA amniotic fluid IL-6 (pg/ml)	1091.7 (701.1–1965.6)	12 328.1 (6138.7–132 198.2)	<0.001
Acute histologic chorioamnionitis (n=15)	36.4% (4/11)	73.3% (11/15)	0.06
Acute funisitis (n=12)	27.3% (3/11)	60% (9/15)	0.098

AF: amniotic fluid; GA: gestational age; WBC: white blood cell; ELISA: enzyme linked immunosorbent assay; IL: interleukin.